Creo Medical Group (LON:CREO) Stock Price Up 7.5% – Here’s What Happened

Creo Medical Group PLC ( LON:CREO – Get Free Report )’s share price traded up 7.5% during trading on Tuesday . The company traded as high as GBX 20.

40 ($0.26) and last traded at GBX 19.99 ($0.



25). 621,117 shares changed hands during mid-day trading, a decline of 14% from the average session volume of 718,493 shares. The stock had previously closed at GBX 18.

60 ($0.23). Creo Medical Group Stock Up 1.

5 % The stock has a market cap of £71.63 million, a P/E ratio of -330.00 and a beta of 0.

86. The company has a quick ratio of 2.19, a current ratio of 3.

24 and a debt-to-equity ratio of 29.96. The company has a 50-day simple moving average of GBX 17.

57 and a two-hundred day simple moving average of GBX 24.90. Insider Buying and Selling In other Creo Medical Group news, insider Richard John Rees acquired 98,000 shares of the business’s stock in a transaction dated Thursday, October 24th.

The shares were purchased at an average cost of GBX 20 ($0.25) per share, for a total transaction of £19,600 ($24,524.52).

Also, insider Kevin Crofton bought 1,179,000 shares of Creo Medical Group stock in a transaction dated Friday, December 13th. The shares were acquired at an average cost of GBX 17 ($0.21) per share, for a total transaction of £200,430 ($250,788.

29). Insiders have bought a total of 4,193,666 shares of company stock valued at $92,002,984 over the last three months. 22.

43% of the stock is owned by company insiders. About Creo Medical Group Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.

Featured Stories Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter ..